drugset / Trial / NCT01329900
Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to learn if it is possible to collect stem cells after ofatumumab and chemotherapy treatment. This study will also evaluate side-effects, number of stem cells collected, and the number of procedures that are needed to collect enough stem cells.
Timeline
- Start
- 2011-08-22
- Primary completion
- 2019-07-21
- Completion
- 2019-07-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ofatumumab | Monoclonal antibody | 2000 mg | Intravenous |
| Background | 2-MERCAPTOETHANESULFONIC ACID | Small molecule | 2.66 g | Intravenous |
| Background | Etoposide | Small molecule | 150 mg/m2 | Intravenous |
| Background | G-CSF | Unknown | 6 ug/kg | Subcutaneous |
| Background | Ifosfamide | Small molecule | 3.33 g | Intravenous |